Succimer

DRUG3 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), M.D. Anderson Cancer Center

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 PositiveHigh Risk Myelodysplastic SyndromeLead ExposureLead PoisoningMyelodysplastic Syndrome

Phase 1

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

RecruitingNCT03630991

M.D. Anderson Cancer CenterAcute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive +15

Start: 2018-10-11End: 2027-04-30Target: 58Updated: 2026-08-25

Phase 3

Treatment of Lead-Exposed Children Trial

CompletedNCT00342849

National Institute of Environmental Health Sciences (NIEHS)Lead Exposure

Start: 1994-07-15End: 2015-06-10Updated: 2018-04-05

Unknown Phase

Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children

CompletedNCT00004838

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Lead Poisoning

Start: 1997-09-30End: 1998-07-31Target: 175Updated: 2005-06-24